Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Frontiers in Genetics|February 4, 2012
A comparison of association methods for cytotoxicity mapping in pharmacogenomicsChad Brown, Tammy M Havener, Lorraine Everitt, et al.Pharmacogenomics|August 29, 2015
Evaluating the role of admixture in cancer therapy via in vitro drug response and multivariate genome-wide associationsJohn Jack, Tammy M Havener, Howard L McLeod, et al.ACS Omega|March 18, 2024
Identification of New Modulators and Inhibitors of Palmitoyl-Protein Thioesterase 1 for CLN1 Batten Disease and CancerAna C Puhl, Renuka Raman, Tammy M Havener, et al.Biodata Mining|December 14, 2012
Multivariate methods and software for association mapping in dose-response genome-wide association studiesChad C Brown, Tammy M Havener, Marisa Wong Medina, et al.Frontiers in Genetics|November 5, 2019
Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell LinesKyle R Roell, Tammy M Havener, David M Reif, et al.Peerj|November 3, 2018
The influence of Neanderthal alleles on cytotoxic responseFarida S Akhtari, Tammy M Havener, Masahide Fukudo, et al.Peerj|May 9, 2017
Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trialSkylar W Marvel, Daniel M Rotroff, Michael J Wagner, et al.Pharmacogenomics|January 22, 2014
Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell linesChad C Brown, Tammy M Havener, Marisa W Medina, et al.Pharmacogenetics and Genomics|September 17, 2020
Race and smoking status associated with paclitaxel drug response in patient-derived lymphoblastoid cell linesFarida S Akhtari, Tammy M Havener, Daniel L Hertz, et al.Frontiers in Genetics|October 25, 2016
Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug ResponseHillary T Graham, Daniel M Rotroff, Skylar W Marvel, et al.Pageof 3